Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1985;65:60-66
© 1985 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HACKER, N. F.
Right arrow Articles by LAGASSE, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HACKER, N. F.
Right arrow Articles by LAGASSE, L. D.

Whole Abdominal Radiation as Salvage Therapy for Epithelial Ovarian Cancer

NEVILLE F. HACKER, MD, JONATHAN S. BEREK, MD, C. MICHELLE BURNISON, MD, A. PETER M. HEINTZ, MD, GUY J. F. JUILLARD, MD and LEO D. LAGASSE, MD

From the Division of Gynecology and Department of Radiation Oncology, UCLA School of Medicine; and The Jonsson Comprehensive Cancer Center, Los Angeles, California.

Thirty patients found to have residual epithelial ovarian cancer at second-look laparotomy were treated with whole abdominal radiation as salvage therapy. Dosage fractions were 120 rad per day until 3000 rad were delivered, then the pelvis was boosted to 5000 rad at 180 rad per day. Fourteen patients (47%) completed therapy without interruption and seven (23%) completed therapy with interruptions due to myelosuppression ranging from one to four weeks. Therapy was not completed in nine patients (30%). Four of 16 patients (25%) with microscopic residual disease before radiation remain alive and free of disease at 22 to 41 months. Two of six (33%) patients with minimal (≤ 5 mm) residual disease remain alive and free of disease 19 to 40 months after radiation treatment. Patients with residual nodules greater than 5 mm uniformly did poorly. Patients who progressed on primary chemotherapy had a median survival of seven months, compared with more than 38 months for chemotherapy responders. Chronic bowel morbidity was a significant problem, with 30% of patients surviving at least four months from completion of radiation requiring laparotomy for small bowel obstruction. These preliminary results suggest that whole abdominal radiation may be useful in the management of patients who have responded to primary chemotherapy, but the benefit is confined to those patients who have minimal or microscopic disease at second-look laparotomy.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
M. Elsheikh, D. B. Dunger, G. S. Conway, and J. A. H. Wass
Turner's Syndrome in Adulthood
Endocr. Rev., February 1, 2002; 23(1): 120 - 140.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Foudila, V. Soderstrom-Anttila, and O. Hovatta
Turner's syndrome and pregnancies after oocyte donation
Hum. Reprod., February 1, 1999; 14(2): 532 - 535.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American College of Obstetricians and Gynecologists.